PharmiWeb.com - Global Pharma News & Resources

Clinical research - Press Releases

Date Title Company
23-Feb-2021 Registration is open for SMi’s 4th Annual Pharmaceutical Microbiology West Coast 2021 SMi Group
23-Feb-2021 Diaprost Announces Promising New Study for Patients with Metastatic PCa Diaprost
23-Feb-2021 2020 clinical trials database report confirms the UK as an internationally attractive clinical space for the development of cell and gene therapies Cell and Gene Therapy Catapult (CGT Catapult)
23-Feb-2021 Global Travel Vaccines Market 2021-2026 by Regions, Type, Application and Major Industry Players like LG Life Sciences, Roche, Lupin, Takeda Pharmaceutical Introspective Market Research
23-Feb-2021 Comprehensive Study on Flu vaccine Market 2021 by Top Leading Vendors Hualan Bio, Changchun Bio, Alephbio, Sinovac Introspective Market Research
19-Feb-2021 NovalGen announces updates to its executive management team NovalGen
19-Feb-2021 Global Virology Market worth US$ 3.7 Billion 2030 with a CAGR of 9.9% Prophecy Market Insights
19-Feb-2021 PharmiWeb.Jobs Welcomes Enara Bio PharmiWeb.Jobs
19-Feb-2021 Five Key Reasons to Attend SMi’s 21st Annual Pain Therapeutics Conference SMi Group
19-Feb-2021 2020 Prediction and Current COVID-19 Scenario for Global Corynebacterium Glutamicum Technology Market market Prophecy Market Insights
18-Feb-2021 Exclusive Chair Interview with Justin Mason-Home ahead of SMi’s 5th Annual Highly Potent Active Pharmaceutical Ingredients Conference (HPAPi) SMi Group
18-Feb-2021 PharmiWeb.Jobs Welcomes Achieva Group Ltd Achieva Group Ltd
17-Feb-2021 ValiRx plc Extension of Collaboration Agreement ValiRx plc
17-Feb-2021 PTC Therapeutics Reports the Initiation of the Second Stage of the FITE19 Phase 2/3 Clinical Trial Evaluating PTC299 for the Treatment of COVID-19 PTC Therapeutics, Inc
17-Feb-2021 Aker BioMarine enters into research collaboration for Alzheimer’s Aker BioMarine
17-Feb-2021 Researchers discover promising biomarkers to diagnose mild traumatic brain injury University of Eastern Finland
17-Feb-2021 IDMC has concluded that OlympiA trial of Lynparza crossed superiority boundary for invasive disease-free survival vs. placebo at planned interim analysis AstraZeneca
16-Feb-2021 Healthtech company Raremark® reboots as XperiomeTM to drive increased value for rare disease patients and researchers Raremark®
15-Feb-2021 Global Natural Killer Cells Therapeutics Market is Anticipated to Reach $5,096 million by 2026 at a CAGR of 17.4%| Apex Market Research Apex Market Research
12-Feb-2021 PHARMASEAL’s Engility® platform fights off competition to be selected by award-winning US Medical Device company PHARMASEAL